Positron Emission Tomography (PET) and Computer Tomography (CT) scanners are combined to provide utmost diagnostic capabilities to patients. This combination produces a highly sensitive imaging and detects diseases at an early stage that are often undetected by CT alone or by other imaging procedures such as magnetic resonance imaging (MRI). The CT component of the system adds anatomical information to the PET scan and provides accurate information on the location of disease in the body. These equipment are used for diagnosis of different types of cancers, such as colorectal cancers and lymphomas, as well as some neurological and cardiac conditions.
Market Dynamics
Increasing prevalence of various chronic diseases such as different types of cancer, heart conditions, and neurological disorders demand disease diagnosis at early stage. For instance, in 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the U.S. It is a powerful tool for determining and diagnosing the stage of many cancer types, including breast, brain, cervical, colorectal, esophageal, head and neck, lung, lymphoma, melanoma, pancreatic, and thyroid cancers. PET/CT is also finding potential value for radiation therapy planning. With recent advances in intensity-modulated radiation therapy, it is possible to treat tumors while reducing radiation doses to non-targeted organs when compared with traditional techniques.
PET-CT scans can also detect early onset of neurological disorders such as Alzheimer’s disease. It is frequently used to identify areas of the brain causing epileptic seizures. However, PET-CT scan is not recommended for all patients due to harmful radiation that causes side effects to the body. For instance, it is not suitable for pregnant women, as the radiation could harm the baby.
Key features of the study:
- This report provides in-depth analysis of the PET-CT scanner device market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period 2018 – 2026, considering 2017 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global PET-CT scanner device market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include General Electric Co., Hitachi, Ltd., Mediso Ltd., Koninklijke Philips N.V., PerkinElmer, Inc., Positron Corporation, Siemens AG, Shimadzu Corporation, Toshiba Corporation, and Yangzhou Kindsway Biotech Co. Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global PET-CT scanner device market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global PET-CT Scanner Device Market, By Detector Type:
- FluroDeoxyGlucose (FDG)
- 62CU ATSM
- FMISO
- Gallium
- Thallium
- Others
- Global PET-CT Scanner Device Market, By Setting:
- Global PET-CT Scanner Device Market, By Application:
- Cardiology
- Oncology
- Neurology
- Others
- Global PET-CT Scanner Device Market, By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
- Global PET-CT Scanner Device Market, By Region:
- North America
- By Country:
- By Detector Type:
- FluroDeoxyGlucose (FDG)
- 62CU ATSM
- FMISO
- Gallium
- Thallium
- Others
- By Setting:
- By Application:
- Cardiology
- Neurology
- Oncology
- Others
- By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Detector Type:
- FluroDeoxyGlucose (FDG)
- 62CU ATSM
- FMISO
- Gallium
- Thallium
- Others
- By Setting:
- By Application:
- Cardiology
- Neurology
- Oncology
- Others
- By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Detector Type:
- FluroDeoxyGlucose (FDG)
- 62CU ATSM
- FMISO
- Gallium
- Thallium
- Others
- By Setting:
- By Application:
- Cardiology
- Neurology
- Oncology
- Others
- By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Detector Type:
- FluroDeoxyGlucose (FDG)
- 62CU ATSM
- FMISO
- Gallium
- Thallium
- Others
- By Setting:
- By Application:
- Cardiology
- Neurology
- Oncology
- Others
- By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Detector Type:
- FluroDeoxyGlucose (FDG)
- 62CU ATSM
- FMISO
- Gallium
- Thallium
- Others
- By Setting:
- By Application:
- Cardiology
- Neurology
- Oncology
- Others
- By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
- Africa
- By Country:
- South Africa
- Central Africa
- North Africa
- By Detector Type:
- FluroDeoxyGlucose (FDG)
- 62CU ATSM
- FMISO
- Gallium
- Thallium
- Others
- By Setting:
- By Application:
- Cardiology
- Neurology
- Oncology
- Others
- By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
- Company Profiles
- General Electric Co.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Hitachi, Ltd.
- Mediso Ltd.
- Koninklijke Philips N.V.
- PerkinElmer, Inc.
- Positron Corporation
- Siemens AG
- Shimadzu Corporation
- Toshiba Corporation
- Yangzhou Kindsway Biotech Co. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
